Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow HARROW, INC.

Get SEC filing alerts via email and in your feed for HARROW, INC.

HROW HROWL HROWM

HARROW, INC.

About HARROW, INC.

Harrow, Inc. is a pharmaceutical company specializing in ophthalmic products, including FDA-approved branded drugs and compounded medications. It serves U.S. eye care professionals with a broad portfolio of prescription and non-prescription treatments for conditions like dry eye, infections, inflammation, and surgical needs. The company owns ImprimisRx, a leading ophthalmology-focused compounding business, and leverages proprietary formulations, patents, and strategic licensing to provide accessible, affordable eye care solutions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from HARROW, INC.

1
1
HARROW, INC. Harrow, Inc. Reports Decline in Revenue and Increased Net Loss in Q1 2026

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
HARROW, INC. Harrow, Inc. Reports 36.4% Revenue Growth to $272.3 Million, Net Loss Improves

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
HARROW, INC. Harrow, Inc. Reports 45.1% Revenue Growth and Net Income Turnaround in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
HARROW, INC. Harrow, Inc. Reports 30% Revenue Growth and Net Income Turnaround in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
HARROW, INC. Harrow, Inc. Reports 38.3% Revenue Growth but Wider Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
HARROW, INC. Harrow, Inc. Reports 53.4% Revenue Growth to $199.6 Million in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
HARROW, INC. Harrow, Inc. Reports 44% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments